A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukaemia effect of allogeneic bone marrow transplantation
β Scribed by Koichi Hattori; Takao Hirano; Hiroaki Miyajima; Norifumi Yamakawa; Shoji Ikeda; Kohichiro Yoshino; Masatoshi Tateno; Kazuo Oshimi; Nobuhiko Kayagaki; Hideo Yagita; Ko Okumura
- Book ID
- 108672222
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 613 KB
- Volume
- 105
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Non-melanoma skin carcinoma is more common in transplant recipients, probably because of immunosuppression. an increased risk of developing melanoma could be a late effect of transplantation. the number of naevi, which is a risk marker for melanoma, is increased in renal transplant r
Patients undergoing bone marrow transplantation are at high risk of developing acute graft-versus-host disease (GVHD) which is a primary limiting factor for this procedure inasmuch as it is responsible for high morbidity rates and is associated with poor survival outcome. To provide improved treatme
In vitro depletion of mature pan-T lymphocytes has been widely and successfully used to prevent acute graft-versus-host disease (GVHD) after allogeneic bone-marrow transplantation (BMT). However, this procedure has been associated with a high incidence of graft failure and leukemic relapse. In this